MarkosWeb

covid-19 widget

imbruvica.com

Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma Treatment IMBRUV...

edit
Discover IMBRUVICA a chronic lymphocytic leukemia and mantle cell lymphoma treatment for adult patients who have received at least one prior treatment



Rating:
0 of 5 ( votes)
Homepage links:
internal 19, external 4
HTML validation:
OK
DNS resolve:
False explanation
Domain worth:
$22,255
Health score:
5.61%
Domain registrar:
GODADDY.COM, LLC domain profile
Domains using same registrar:1,364,460

Technical

Website availability: (is site down?)
Used technologies:
Analytics
Google Analytics (version ))
Javascript frameworks
jQuery (version 1.8.3)
Operating systems
Red Hat
Programming languages
PHP (version 5.3.3)
Web servers
Apache (version 2.2.3)
Hosting abuse phone:
office +1-210-312-4000
Hosting abuse mail:
Domain IP:
69.20.56.54 United States
DNS Resolve:
False explanation
Public registrar record:

Profile

Domain age:
7 years and 3 months
Domain worth:
$22,255
Health score:
5.61%
Domain score widget:
Domain worth widget:
MarkosWeb certification:

Social #imbruvica.com

MarkosWeb reviews:

Advertising

AdSense Checker: (AdSense Checker:)
Is domain banned from using Google Adsense?
Tags prominence:
(important page elements, estimated advertising value)
u s (91%, $2.16), healthcare provider (3%), many people (3%), side effects (2%, $1.72), general information (1%, $1.27)
Ads SERP visibility: based on research of 16,000,000 keywords

SEO

Homepage links:
internal 19, external 4
HTML validation:
OK
Title:
Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma Treatment IMBRUVICA ibrutinib
Meta-description:
Discover IMBRUVICA a chronic lymphocytic leukemia and mantle cell lymphoma treatment for adult patients who have received at least one prior treatment
MarkosWeb Domain RSS:
Get the latest updates on imbruvica.com via RSS
SERP organic visibility: based on research of 16,000,000 keywords
This website does not receive any organic traffic (based on our research of 16 million keywords conducted 21 April 2012)